Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?

• Autorzy: Hyung Han , Sae Choi , Wan Kim , Tae Song , Sang Choi
• Języki publikacji: EN

Abstrakty

EN

A 64-year-old man with a history of gallstones, common bile duct stones, chronic hepatitis B virus infection, and hepatic cirrhosis with a Child-Pugh score B was satisfactorily treated for hepatocellular carcinoma with radiofrequency ablation and transarterial chemoembolization. His course, however, was complicated by gallbladder actinomycosis 14 months after treatment, resulting in acute cholecystitis. Such a chain of events suggests that gallbladder actinomycosis may develop after radiofrequency ablation and transarterial chemoembolization in patients who are known to have gallstones and that asymptomatic gallstones should be treated before the application of nonsurgical, but invasive procedures for hepatocellular carcinoma.

Słowa kluczowe

EN

Actinomycosis; Gallstone; Hepatocellular carcinoma; Chemoembolization; Radiofrequency ablation

• Czasopismo: Open Medicine
• Rocznik: 2011
• Tom: 6
• Numer: 3
• Strony: 300-304

Daty

wydano

2011-06-01

online

2011-04-08

Twórcy

autor

Hyung Han

• Department of Surgery, Korea University Ansan Hospital, Gojan 1-dong, Danwon-gu, Ansan-si, Gyeonggi-do, 425-707, Republic of Korea

autor

Sae Choi

• Department of Surgery, Korea University Guro Hospital, 80 Guro-dong, Guro-gu, Seoul, 152-703, Republic of Korea

autor

Wan Kim

• Department of Surgery, Korea University Guro Hospital, 80 Guro-dong, Guro-gu, Seoul, 152-703, Republic of Korea,

autor

Tae Song

• Department of Surgery, Korea University Ansan Hospital, Gojan 1-dong, Danwon-gu, Ansan-si, Gyeonggi-do, 425-707, Republic of Korea

autor

Sang Choi

• Department of Surgery, Korea University Guro Hospital, 80 Guro-dong, Guro-gu, Seoul, 152-703, Republic of Korea

Bibliografia

• [1] Russo T. Agents of actinomycosis. In Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. New York: Churchill-Livingstone, 2000. pp. 2645–2654
• [2] Charalabopoulos K, Charalabopoulos AK, Papalimneou V, et al. Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentation. Chemotherapy. 2003;49:209–211 http://dx.doi.org/10.1159/000071147[Crossref]
• [3] Dominguez DC, Antony SJ. Actinomyces and nocardia infections in immunocompromised and nonimmunocompromised patients. J Natl Med Assoc. 1999;91:35–39 [PubMed]
• [4] Fry RD, Birnbaum EH, Lacey DL. Actinomyces as a cause of recurrent perianal fistula in the immunocompromised patient. Surgery. 1992;111:591–594
• [5] Richman M, Jeng A. Intra-abdominal co-infection with Mycobacterium bovis and Actinomyces in an AIDS patient: the first reported case and review. J Infect. 2007;55:e115–118 http://dx.doi.org/10.1016/j.jinf.2007.07.006[Crossref]
• [6] Leach TD, Sadek SA, Mason JC. An unusual abdominal mass in a renal transplant recipient. Transpl Infect Dis. 2002;4:218–222 http://dx.doi.org/10.1034/j.1399-3062.2002.t01-1-01009.x[Crossref]
• [7] Freland C, Massoubre B, Horeau JM, et al. Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect. 1987;15:251–257 http://dx.doi.org/10.1016/S0163-4453(87)92753-8[Crossref]
• [8] Ormsby AH, Bauer TW, Hall GS. Actinomycosis of the cholecystic duct: case report and review. Pathology. 1998;30:65–67 http://dx.doi.org/10.1080/00313029800169695[Crossref]
• [9] Wagenlehner FM, Mohren B, Naber KG, et al. Abdominal actinomycosis. Clin Microbiol Infect. 2003;9:881–885 http://dx.doi.org/10.1046/j.1469-0691.2003.00653.x[Crossref]
• [10] Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007;85:16–23 http://dx.doi.org/10.1038/sj.icb.7100009[Crossref]
• [11] Santos LD, Rogan KA, Kennerson AR. Cytologic diagnosis of suppurative cholecystitis due to Candida albicans and actinomyces. A report of 2 cases. Acta Cytol. 2004;48:407–410 http://dx.doi.org/10.1159/000326394[Crossref]
• [12] Hamid D, Baldauf JJ, Cuenin C, et al. Treatment strategy for pelvic actinomycosis: case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2000;89:197–200 http://dx.doi.org/10.1016/S0301-2115(99)00173-6[Crossref]
• [13] Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984;94:1198–1217 http://dx.doi.org/10.1288/00005537-198409000-00013[Crossref]

Identyfikatory

DOI

10.2478/s11536-011-0006-4